V8 Diagnostic Ultrasound System

The V8 Diagnostic Ultrasound System is designed to provide comprehensive, multi-modal ultrasound imaging and body fluid analysis for a wide array of clinical diagnostic applications. It employs advanced software-controlled ultrasound technology, incorporating AI-driven features like NerveTrack and UterineAssist, along with new transducer options, to enhance diagnostic capabilities for healthcare professionals.

The V8 Diagnostic Ultrasound System, manufactured by Samsung Medison, is a versatile medical imaging device engineered to obtain ultrasound images and analyze body fluids for diagnostic purposes. It supports a wide range of clinical applications, including fetal/obstetrics, abdominal, gynecology, intra-operative, pediatric, small organ, neonatal and adult cephalic, trans-rectal, trans-vaginal, musculoskeletal (conventional and superficial), urology, adult and pediatric cardiac, thoracic, trans-esophageal cardiac, and peripheral vessel imaging. The system is intended for operation by, or under the direct supervision of, appropriately trained healthcare professionals in clinical settings such as hospitals, private practices, and clinics to aid in patient diagnosis. This mobile, software-controlled ultrasound system acquires and displays data through various modes: 2D, Color Doppler, Power Doppler (PD), M mode, Pulsed Wave (PW) Doppler, Continuous Wave (CW) Doppler, Tissue Doppler Imaging (TDI), Tissue Doppler Wave (TDW), ElastoScan Mode, combined modes, and multi-image (dual, quad), 3D/4D modes. It facilitates the measurement of anatomical structures and offers analysis packages, displaying real-time mechanical and thermal indices. Key technological components include AI-based software features like NerveTrack and UterineAssist (for non-invasive uterine parameter detection and measurement), integration of new transducers (CA4-10M, LA4-18A, LA3-22AI), and a thoracic application for lung scanning. The system's safety and effectiveness are substantiated by non-clinical tests covering acoustic output, biocompatibility, software functionality, cleaning/disinfection, and adherence to thermal, electrical, electromagnetic, and mechanical safety standards.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the AI-driven UterineAssist feature compare in accuracy and efficiency to traditional manual methods for uterine measurements across diverse patient populations?; What specific enhancements or advantages do the new transducers (CA4-10M, LA4-18A, LA3-22AI) offer in terms of image resolution, penetration depth, or ergonomic design for their intended applications?; Can the NerveTrack AI feature reliably identify and track smaller or deeper peripheral nerves, and how has its performance been validated across different anatomical regions?; What are the quantitative performance metrics (e.g., sensitivity, specificity, image quality scores) for the thoracic application, particularly in lung scanning for conditions like pleural effusions or consolidations, compared to existing systems?; Beyond the listed modes, what is the specific functionality and clinical validation for ElastoScan Mode on the V8 system, and how does it compare to other elastography techniques?